Selank for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Selank for Health & Longevity

Created on 07/02/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

Selank is a synthetic peptide used in Russia since 2009 to ease anxiety, reportedly without the drowsiness, memory dulling, or dependence of conventional sedatives, alongside modest gains in focus, mood, and stress resilience. Nearly all human data come from small, unreplicated Russian studies; any link to long-term health remains theoretical, and unregulated product quality is a real concern. (Full Review)

Protocol

Standard Dose
250–3,000 mcg/day intranasal
0.15% solution, roughly 2–4 drops per nostril, one to three times daily; courses of about 10–14 days
Timing
Split, earlier in day
Two to three times daily (e.g., morning and midday); avoid dosing near sleep
Cycling
Course-based, cycled
Courses separated by off-periods; no support for indefinite continuous use
Time to effect
Anxiety Reduction
1–2 weeks
Subtle onset over 1–3 days, with noticeable reduction over a course
Cognitive Effects
Over the course
Improved focus tends to build over the course rather than appear immediately
Acute Calming
Within hours
Some users report acute calming, though this pattern is less consistent

Benefits

Contraindications
  • Pregnant or breastfeeding individuals
  • People with autoimmune or significant immune-mediated conditions
  • Serious psychiatric illness managed with multiple central nervous system agents
  • Anyone unable to verify product quality
    •
Key Interactions
  • Benzodiazepines (diazepam, phenazepam, alprazolam)
  • Other GABA-active or sedating drugs (barbiturates, "Z-drugs" such as zolpidem, gabapentinoids)
  • Alcohol and other over-the-counter sedatives (e.g., antihistamines such as diphenhydramine)
  • Antidepressants and other serotonergic/dopaminergic agents (e.g., SSRIs such as sertraline)
  • Supplements with calming/GABAergic or serotonergic activity (L-theanine, magnesium, valerian, kava, 5-HTP, high-dose glycine)
  • Immunomodulatory agents or immunosuppressants
    •

Risk & Side Effects

  • High: [risks_high]
    •
  • Medium: [risks_medium]
    •
  • Low: Generally mild, transient adverse effects; nasal and local irritation (intranasal route)
    •
  • Speculative: Unknown long-term and immune effects; product quality and contamination risks; additive central nervous system effects
    •

Monitoring

Marker Target Why
hs-CRP (high-sensitivity C-reactive protein) < 1.0 mg/L Tracks systemic inflammation, relevant if pursuing an anti-inflammatory/adaptogenic rationale
Fasting glucose 70–85 mg/dL Context for the speculative metabolic-syndrome findings
Fasting insulin 2–5 µIU/mL Metabolic context if a metabolic rationale is being pursued
Lipid panel (total, LDL, HDL, triglycerides) Triglycerides < 80 mg/dL; HDL > 50 mg/dL Context for reported lipid effects in animal metabolic-syndrome models

Cadence: Reassess subjective anxiety, mood, focus, and sleep at roughly 1 week and at the end of a 2–4 week course, then again after an off-period; optional labs rechecked every 3–6 months only if there is a specific reason.

Qualitative Assessment

  • Reduction in day-to-day anxiety and a sense of calm without sedation
  • Improved focus, mental clarity, and freedom from "brain fog"
  • Stable or improved mood
  • Sleep quality (improved indirectly via lower anxiety; not disrupted)
  • Subjective stress resilience — feeling less reactive to stressors
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.